2-241869878-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000343216.3(RTP5):c.122G>A(p.Gly41Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000147 in 1,583,758 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G41S) has been classified as Likely benign.
Frequency
Consequence
ENST00000343216.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RTP5 | NM_173821.3 | c.122G>A | p.Gly41Asp | missense_variant | 1/2 | ENST00000343216.3 | NP_776182.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RTP5 | ENST00000343216.3 | c.122G>A | p.Gly41Asp | missense_variant | 1/2 | 1 | NM_173821.3 | ENSP00000345374 | P1 | |
RTP5 | ENST00000419912.1 | c.122G>A | p.Gly41Asp | missense_variant, NMD_transcript_variant | 1/3 | 5 | ENSP00000397191 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152236Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000166 AC: 35AN: 210230Hom.: 1 AF XY: 0.000208 AC XY: 24AN XY: 115410
GnomAD4 exome AF: 0.000148 AC: 212AN: 1431522Hom.: 1 Cov.: 31 AF XY: 0.000173 AC XY: 123AN XY: 710390
GnomAD4 genome AF: 0.000138 AC: 21AN: 152236Hom.: 0 Cov.: 34 AF XY: 0.000161 AC XY: 12AN XY: 74364
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 03, 2022 | The c.122G>A (p.G41D) alteration is located in exon 1 (coding exon 1) of the RTP5 gene. This alteration results from a G to A substitution at nucleotide position 122, causing the glycine (G) at amino acid position 41 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at